iScienceBioinformaticsPeer-reviewed journal article
Elucidating immune-related gene transcriptional programs via factorization of large-scale RNA-profiles
Shan HeiD, Matthew M. GubiniD, Hind RafeiiD, Rafet BaşariD, Merve DedeiD, Xianli JiangiD, Qingnan LiangiD, Yukun TaniD, Kun Hee KimiD, Maura L. GillisoniD, Katayoun RezvaniiD, Weiyi PengiD, Cara L. HaymakeriD, Sharia D. HernandeziD, Luisa Maren Solis, Vakul MohantyiD, Ken CheniD
Abstract
Recent developments in immunotherapy, including immune checkpoint blockade (ICB) and adoptive cell therapy, have encountered challenges such as immune-related adverse events and resistance, especially in solid tumors. To advance the field, a deeper understanding of the molecular mechanisms behind treatment responses and resistance is essential. However, the lack of functionally characterized immune-related gene sets has limited data-driven immunological research. To address this gap, we adopted non-negative matrix factorization on 83 human bulk RNA-seq datasets and constructed 28 immune-specific gene sets. After rigorous immunologist-led manual annotations and orthogonal validations across immunological contexts and functional omics data, we demonstrated that these gene sets can be applied to refine pan-cancer immune subtypes, improve ICB response prediction and functionally annotate spatial transcriptomic data. These functional gene sets, informing diverse immune states, will advance our understanding of immunology and cancer research.
- organism: human
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: statistical model
- Citations
- 1
- FWCI
- 0.17
- Field percentile
- 48th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- easier: interpretable predictions of antitumor immune response from bulk RNA-seq data
Óscar Lapuente-Santana, Fédérico Marini, … Federica Eduati·bioRxiv·Nov 26, 2021
- Probabilistic Graphical Models Relate Immune Status With Response To Neoadjuvant Chemo-Therapy In Breast Cancer
Andrea Zapater-Moros, Angelo Gámez-Pozo, … Juan Ángel Fresno Vara·bioRxiv·Oct 27, 2017
- ILnc: Prioritizing Long Non-coding RNAs for Pan-cancer Analysis of Immune Cell Infiltration
Xinhui Li, Changbo Yang, … Xia Li·bioRxiv·Mar 10, 2022
- Predicting tumor immune microenvironment and checkpoint therapy response of head & neck cancer patients from blood immune single-cell transcriptomics
Yingying Cao, Tiangen Chang, … Eytan Ruppin·Cancer Research CommunicationsPeer-reviewed·Aug 8, 2024
- Dissecting Response to Cancer Immunotherapy by Applying Bayesian Network Analysis to Flow Cytometry Data
Andréi S. Rodin, Grigoriy Gogoshin, … Peter P. Lee·International Journal of Molecular SciencesPeer-reviewed·Feb 26, 2021
- TCCIA: A Comprehensive Resource for Exploring CircRNA in Cancer Immunotherapy
Shixiang Wang, Yi Xiong, … Jian‐Guo Zhou·Journal for ImmunoTherapy of CancerPeer-reviewed·Jan 1, 2024